Title : Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease.

Pub. Date : 2019 Feb

PMID : 30689194






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tolvaptan [Jynarque (USA); Jinarc (EU, Canada); Samsca (Japan)] is a highly selective vasopressin V2 receptor antagonist approved for the treatment of autosomal dominant polycystic kidney disease (ADPKD). Tolvaptan arginine vasopressin receptor 2 Homo sapiens